Share Twitter LinkedIn Facebook Email Habte Yimer, MD from Texas Oncology discusses safety for the 1st cycle of CyBorD and how it decreases infusion time from 7 hrs. to 4.3 hours at the 2017 American Society of Hematology.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read